These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22257824)

  • 1. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: study with artificial emulsions.
    Carneiro MM; Miname MH; Gagliardi AC; Pereira C; Pereira AC; Krieger JE; Maranhão RC; Santos RD
    Atherosclerosis; 2012 Mar; 221(1):268-74. PubMed ID: 22257824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hypercholesterolemia carrying the same null LDL receptor gene mutation.
    Tremblay AJ; Lamarche B; Ruel I; Hogue JC; Bergeron J; Gagné C; Couture P
    Atherosclerosis; 2004 Feb; 172(2):367-73. PubMed ID: 15019548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons.
    Wajchenberg BL; Amâncio RF; Santomauro AT; Maranhão RC
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):347-52. PubMed ID: 15355451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease.
    Maranhão RC; Feres MC; Martins MT; Mesquita CH; Toffoletto O; Vinagre CG; Gianinni SD; Pileggi F
    Atherosclerosis; 1996 Sep; 126(1):15-25. PubMed ID: 8879430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia.
    Cabezas MC; de Bruin TW; Westerveld HE; Meijer E; Erkelens DW
    J Intern Med; 1998 Oct; 244(4):299-307. PubMed ID: 9797493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma kinetics of an artificial emulsion resembling chylomicrons in patients with chronic lymphocytic leukemia.
    Sakashita AM; Bydlowski SP; Chamone DA; Maranhão RC
    Ann Hematol; 2000 Dec; 79(12):687-90. PubMed ID: 11195006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.
    Soufi M; Kurt B; Schweer H; Sattler AM; Klaus G; Zschocke J; Schaefer JR
    Atheroscler Suppl; 2009 Dec; 10(5):5-11. PubMed ID: 20129366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipolysis of emulsion models of triglyceride-rich lipoproteins is altered in male patients with abdominal aorta aneurysm.
    Hosni JJ; Vinagre CG; Mady C; Maranhão RC
    Braz J Med Biol Res; 2007 Mar; 40(3):305-7. PubMed ID: 17334526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test.
    Watts GF; Barrett PH; Marais AD; Dane-Stewart CA; Martins IJ; Dimmitt SB; Redgrave TG
    Atherosclerosis; 2001 Aug; 157(2):519-23. PubMed ID: 11472755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects.
    Mangili OC; Moron Gagliardi AC; Mangili LC; Mesquita CH; Machado Cesar LA; Tanaka A; Schaefer EJ; Maranhão RC; Santos RD
    Atherosclerosis; 2014 Mar; 233(1):319-25. PubMed ID: 24503114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of chylomicron-like emulsions in patients with Hodgkin's and with non-Hodgkin's lymphoma.
    Gonçalves RP; Hungria VT; Chiattone CS; Pozzi DB; Maranhão RC
    Leuk Res; 2003 Feb; 27(2):147-53. PubMed ID: 12526920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chylomicron metabolism is markedly altered in systemic lupus erythematosus.
    Borba EF; Bonfá E; Vinagre CG; Ramires JA; Maranhão RC
    Arthritis Rheum; 2000 May; 43(5):1033-40. PubMed ID: 10817556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia.
    Santos PC; Morgan AC; Jannes CE; Turolla L; Krieger JE; Santos RD; Pereira AC
    Atherosclerosis; 2014 Mar; 233(1):206-10. PubMed ID: 24529145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed intravascular catabolism of chylomicron-like emulsions is an independent predictor of coronary artery disease.
    Sposito AC; Ventura LI; Vinagre CG; Lemos PA; Quintella E; Santos RD; Carneiro O; Ramires JA; Maranhão RC
    Atherosclerosis; 2004 Oct; 176(2):397-403. PubMed ID: 15380465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of triglyceride-rich lipoproteins and transfer of lipids to high-density lipoproteins (HDL) in vegan and omnivore subjects.
    Vinagre JC; Vinagre CG; Pozzi FS; Slywitch E; Maranhão RC
    Nutr Metab Cardiovasc Dis; 2013 Jan; 23(1):61-7. PubMed ID: 21937206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
    Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
    Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
    Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diurnal rhythms of cholesterol metabolism and plasma clearance of model chylomicrons: comparison of normal and genetically hypercholesterolemic rats (RICO).
    Mortimer BC; Beveridge DJ; Phan CT; Lutton C; Redgrave TG
    Comp Biochem Physiol A Mol Integr Physiol; 1998 Aug; 120(4):671-80. PubMed ID: 9828396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.